Literature DB >> 17392400

Endovascular therapy in the management of moderate and massive haemoptysis.

A Poyanli1, B Acunas, I Rozanes, K Guven, S Yilmaz, A Salmaslioglu, E Terzibasioglu, R Cirpin.   

Abstract

The aim of this study was to retrospectively evaluate 140 patients with severe (97 massive, 43 moderate) haemoptysis treated by bronchial artery embolisation. Between January 1997 and April 2005, 140 patients (120 males and 20 females, aged 23-71 years) with severe haemoptysis considered surgically inoperable because of limited pulmonary reserve were treated by embolisation. The cause of haemoptysis was tuberculosis in 136 patients and malignancy in four. Embolisation succeeded in controlling haemoptysis immediately after the intervention in 138 patients (98.5%) and at 1 month in 126 patients (90%). Severe haemoptysis recurred in 11 patients with prior massive haemoptysis and 3 patients with prior moderate haemoptysis in a mean time of 3.7 months (1-7 months) after the last intervention. The bleeding source was detected during angiography and embolised in 12 of these patients. Two patients with malignant tumour died because of abundant bleeding, following an asymptomatic period of 30 days. There were no procedure-related major complications. Bronchial artery embolisation is a safe and effective palliative treatment alternative in moderate and massive haemoptysis.

Entities:  

Mesh:

Year:  2007        PMID: 17392400     DOI: 10.1259/bjr/34204483

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  19 in total

1.  Bronchial artery embolization for hemoptysis.

Authors:  David R Sopko; Tony P Smith
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 2.  A friend to the airways: a review of the emerging clinical importance of the bronchial arterial circulation.

Authors:  Stephen Osiro; Christopher Wear; Ryan Hudson; Xiao-Xiao Ma; Anna Zurada; Maciej Michalak; Marios Loukas
Journal:  Surg Radiol Anat       Date:  2012-05-03       Impact factor: 1.246

3.  Radiological findings and outcomes of bronchial artery embolization in cryptogenic hemoptysis.

Authors:  Selim Kervancioglu; Nazan Bayram; Feyza Gelebek Yilmaz; Maruf Sanli; Akif Sirikci
Journal:  J Korean Med Sci       Date:  2015-04-15       Impact factor: 2.153

4.  Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysis.

Authors:  Joo-Young Chun; Anna-Maria Belli
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

5.  Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension.

Authors:  Edoardo Rasciti; Nicola Sverzellati; Mario Silva; Andrea Casadei; Domenico Attinà; Massimiliano Palazzini; Nazzareno Galiè; Maurizio Zompatori
Journal:  Radiol Med       Date:  2016-12-26       Impact factor: 3.469

Review 6.  The Diagnosis and Treatment of Hemoptysis.

Authors:  Harald Ittrich; Maximilian Bockhorn; Hans Klose; Marcel Simon
Journal:  Dtsch Arztebl Int       Date:  2017-06-05       Impact factor: 5.594

7.  A retrospective analysis of 334 cases of hemoptysis treated by bronchial artery embolization.

Authors:  Ashu Bhalla; Devasenathipathy Kandasamy; Prasad Veedu; Anant Mohan; Shivanand Gamanagatti
Journal:  Oman Med J       Date:  2015-03

8.  Outcome and complications of bronchial artery embolisation for life-threatening haemoptysis.

Authors:  M M Slattery; A N Keeling; M J Lee
Journal:  Ir J Med Sci       Date:  2008-10-25       Impact factor: 1.568

9.  The impact of coinfection with human immunodeficiency virus and pulmonary tuberculosis on the success of bronchial artery embolisation.

Authors:  M Govind; J Maharajh
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

10.  Double-lumen endobronchial tube in the emergency management of massive hemoptysis.

Authors:  Luciano Santana-Cabrera; Manuela Fernández Arroyo; Alina Uriarte Rodriguez; Manuel Sanchez-Palacios
Journal:  J Emerg Trauma Shock       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.